Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Enzymes
Sort By
Newest First
1 / 1
1 / 1
M&A
Enzymaster’s Sanming Minhe Acquisition Increases Production Capacity by 50% to Keep Pace with Rapidly Growing Demand
Enzymaster
PR-M01-22-14
Jan 20, 2022
Drug Development
A New Approach for Diseases Associated with BH4-Dependent Enzymatic Pathways
Jonathan Reis, Ph.D.
PAP-Q1-20-CL-011
Mar 19, 2020
Chiral Synthesis
Applying Enzymatic Synthesis for Chiral Molecules
Juliette Martin, Ph.D.; Sergio Kreimerman, Ph.D.
Seqens
PAP-Q2-2019-CL-029
May 24, 2019
Launch
New England Biolabs® Launches NEBNext® Enzymatic Methyl-seq (EM-seq™) for Bisulfite-Free Methylation Analysis
New England Biolabs
PR-M05-19-NI-003
May 01, 2019
FDA Fast Track
Enzyvant's Investigational Farber Disease Enzyme Replacement Therapy, RVT-801, Receives FDA Fast Track and Rare Pediatric Disease Designations
Enzyvant
PR-M03-19-NI-073
Mar 26, 2019
Cell and Gene Therapy
BridgeBio Pharma Launches CoA Therapeutics to Target Coenzyme-A for Rare Genetic Disorders
BridgeBio Pharma
PR-M06-18-NI-052
Jun 15, 2018
Drug Discovery
RNA-Modifying Proteins May Provide New Drug Targets
Guy Tiene
Nice Insight
PAO-M05-18-NI-018
May 24, 2018
Acquisition
Almac Expands Analytical Services with BioClin Laboratories Acquisition
Nice Insight
PAO-M11-17-NI-033
Nov 21, 2017
